{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwPKL6cUKDA","type":"Investor","logokey":"$YILqEmtVuPhOAI5dVRC7PIVBwe49xO4KSX6J9OAMZzEcIhU9plZyEZ","name":"Israel Biotech Fund","subtype":"VC and Private Equity","lastupdate":"2023-08-03T00:00:00.000Z","update_date":"2023-08-03T00:00:00.000Z","lastModified":"Mar 20, 2025","active":1,"confidence_score":55,"confidence_score_reason":"product stage, sector, number of employees, business model, tag line, video or image, funding rounds, markets, not claimed","urlname":"israel-biotech-fund","minimal_profile":null,"hide_reason":null,"status":"","fullstatus":"","hide_reason_data":null,"acquired":0,"description_edited":1,"tag_line_edited":0,"isisraeli":1,"country":"Israel","formernames":[],"min_date_investments":"2016-06-01T00:00:00.000Z","hide_reasons":[{"id":"71DetFrndkNwNZufhli91PBqJkgDvyWv0skK3yYHYitL6RnFpb2Uf1","reason":"Pending approval - External entity"},{"id":"bMlvNZGgO393OpCQn2LLGyGQIyzd4aZiwm516IvRMWEx6Fkam4LPsQ","reason":"Firm does not match any of Finder’s investors entities"},{"id":"hUspihf43qDmsZbgaEhZKEfAAW3v31Vgv8cpxJzOvLRPPTJ0F4MHzR","reason":"Pending approval"},{"id":"o9Wzo8oG7DIeZVpiC2CdK6IVPWAA4wFvEE97ITVY0oHo6HyeP4v2YV","reason":"Firm asked to delete"},{"id":"rW7l4bkGn6inVBM54t8wGMz9mlLAxGGZOgTQSofPoEagmlofSfwSil","reason":"Foreign, no presence - no Israeli investments/fund"},{"id":"TW4W1IZcqaOGz6jCahuX2wE03SdSzw54lheysaeW0zOAsmOGBFF014","reason":"Foreign, no presence - not enough investments"},{"id":"wcXeLKSl465vLdJtWXjddE1UVQbANeL8NjdsDpAh0CYTtOJw8wHP97","reason":"Firm asked to hide in the meantime"}],"registrar":"","founded_year":2015,"iia_supported":0,"currently_iia_supported":0,"alternativenames":["IBF"],"managedassets":"$166M","representing":null,"supported_by":"","supported_by_id":"","inisraelsince":"","inisraelsincemonth":"","investment_lower_amount":null,"investment_upper_amount":null,"marketcapital":null,"marketcapitaldate":null,"oneliner":"","website":"https://ibf.fund","sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/10267153","instagram":""},"social":["https://www.linkedin.com/company/10267153"],"flattenedsociallinks":"https://www.linkedin.com/company/10267153","apps":{"appstore":"","googleplay":""},"investmentstage":["Pre-Seed","A Round","Seed"],"about":"Israel Biotech Fund (IBF) invests exclusively in Israeli and Israeli related biotech companies at all development stages. Having started its activity in late 2015, the fund has a rich portfolio with more than 16 portfolio companies at various development stages from different fields as well as significant partnerships with key market players. The fund is committed to seeking high-value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotechnology companies. IBF provides its portfolio companies with hands-on guidance and the necessary resources for long-term sustainable growth. Along with its team, the fund has a group of more than 30 leading pharmaceutical and financial executives acting as advisors to the fund and its portfolio.","founded":"11/2015","education":null,"additional_activities":null,"techcommunityinvolvement":null,"exits":[{"date":"Oct 2023","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"Je7gUzsBzBWLSYmJFmJeKMNyca5vPCyRmJwskLL7Eb9VsNcW45rIvl","mnatype":"Merger","eventtype":"MNAEvent","valuation":"Undisclosed","wasacquired":1,"capitalraised":"Undisclosed","stockexchange":null,"eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"BioSight","acquiredcompany_spac":null,"acquiringcompany_mna":"Ayala Pharmaceuticals","stockexchange_logokey":null,"acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6Y9LoLDA","acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"acquiringcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNrZnJ8LDA","acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_fullurl":"/company_page/biosight","acquiredcompany_mna_logokey":"$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","acquiredcompany_mna_urlname":"biosight","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":0,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":"/company_page/ayala-pharmaceuticals","acquiringcompany_mna_logokey":"$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","acquiringcompany_mna_urlname":"ayala-pharmaceuticals","acquiredcompany_reverse_hidden":null,"acquiredcompany_reverse_fullurl":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"blurFinancialData":"","stockexchange_logourl":"/assets/empty-state.svg","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","acquiringcompany_style":"","acquiringcompany_hiddenCompanyTooltip":"","style":"","hiddenCompanyTooltip":""},{"date":"Mar 2023","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"S6jCdfZHzA9caguDZCfmISP4tQhsNWrBZtCF0IPg2u5HC6CZuvfpPt","mnatype":null,"eventtype":"POEvent","valuation":"Undisclosed","wasacquired":null,"capitalraised":"Undisclosed","stockexchange":"HAM","eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"Vidac Pharma","acquiredcompany_spac":null,"acquiringcompany_mna":null,"stockexchange_logokey":null,"acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6_0ucLDA","acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"acquiringcompany_mna_id":null,"acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_fullurl":"/company_page/vidac-pharma","acquiredcompany_mna_logokey":"$wOvE0qdLetkdWPNbns4g3IHKSA5vEvK1zn22wrB05ULZ3ABW3nGedg","acquiredcompany_mna_urlname":"vidac-pharma","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":null,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":null,"acquiringcompany_mna_logokey":null,"acquiringcompany_mna_urlname":null,"acquiredcompany_reverse_hidden":null,"acquiredcompany_reverse_fullurl":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"blurFinancialData":"","stockexchange_logourl":"/assets/empty-state.svg","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$wOvE0qdLetkdWPNbns4g3IHKSA5vEvK1zn22wrB05ULZ3ABW3nGedg","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""},{"date":"May 2020","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCu4-elCAw","mnatype":null,"eventtype":"POEvent","valuation":"Undisclosed","wasacquired":null,"capitalraised":"$55M","stockexchange":"NASDAQ","eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"Ayala Pharmaceuticals","acquiredcompany_spac":null,"acquiringcompany_mna":null,"stockexchange_logokey":"$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNrZnJ8LDA","acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"acquiringcompany_mna_id":null,"acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_fullurl":"/company_page/ayala-pharmaceuticals","acquiredcompany_mna_logokey":"$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","acquiredcompany_mna_urlname":"ayala-pharmaceuticals","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":null,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":null,"acquiringcompany_mna_logokey":null,"acquiringcompany_mna_urlname":null,"acquiredcompany_reverse_hidden":null,"acquiredcompany_reverse_fullurl":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"blurFinancialData":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""},{"date":"Oct 2018","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODIvZLhCQw","mnatype":null,"eventtype":"POEvent","valuation":"$210M","wasacquired":null,"capitalraised":"$50M","stockexchange":"NASDAQ","eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"Gamida Cell","acquiredcompany_spac":null,"acquiringcompany_mna":null,"stockexchange_logokey":"$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6_pM4KDA","acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"acquiringcompany_mna_id":null,"acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_fullurl":"/company_page/gamida-cell","acquiredcompany_mna_logokey":"$en3ldNUjXmtElFUCM80xLU2SF4I5kExCmXv9w2VUIpPvvDQw7kOyCk","acquiredcompany_mna_urlname":"gamida-cell","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":null,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":null,"acquiringcompany_mna_logokey":null,"acquiringcompany_mna_urlname":null,"acquiredcompany_reverse_hidden":null,"acquiredcompany_reverse_fullurl":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"blurFinancialData":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$en3ldNUjXmtElFUCM80xLU2SF4I5kExCmXv9w2VUIpPvvDQw7kOyCk","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""}],"funds":[{"date":"Apr 2021","name":"2","title":"Fund 2","amount":"$100M","source":"https://en.globes.co.il/en/article-israel-biotech-fund-closes-112m-second-fund-1001366337","eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODHtOriCAw","visibilitytype":"Public","amountvisibility":"Public","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":""},{"date":"Oct 2016","name":"1","title":"Fund 1","amount":"$66M","source":"From Sarit Steinberg","eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCnmpP3CQw","visibilitytype":"Public","amountvisibility":"Public","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":""}],"portfolio":[{"id":"I9HARjQF5otmlJD7xWv0oETmwNgLjC6EzFoHbPp20zuFWqzq01jvW4","name":"4C Biomed","hidden":false,"raised":"undisclosed","founded":"2016","fullurl":"/company_page/4c-biomed","logokey":"$thuLc2yHAfwPbQANfHlfRoN9Kx4b1LugzNBAHsNOIjRDB5ajXfhvFb.png","urlname":"4c-biomed","employees":"1-10","description":"Unlocking the Promise of Immune Checkpoint Inhibitors","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$thuLc2yHAfwPbQANfHlfRoN9Kx4b1LugzNBAHsNOIjRDB5ajXfhvFb.png","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Lq8iIMKDA","name":"AnserBio","hidden":false,"raised":"$6.45M","founded":"2017","fullurl":"/company_page/anserbio","logokey":"$T7m2DQr0aDA5tKAOJPDzuBcKKEbBWqXBoFlUtqrEbrfmer65oVGi08","urlname":"anserbio","employees":"1-10","description":"Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. - ","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":6450000,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T7m2DQr0aDA5tKAOJPDzuBcKKEbBWqXBoFlUtqrEbrfmer65oVGi08","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNrZnJ8LDA","name":"Ayala Pharmaceuticals","hidden":false,"raised":"$102M","founded":"2017","fullurl":"/company_page/ayala-pharmaceuticals","logokey":"$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","urlname":"ayala-pharmaceuticals","employees":"11-50","description":"Targeted Therapies for People with Rare Cancers","fundingstage":"Acquired","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":102000000,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6Y9LoLDA","name":"BioSight","hidden":false,"raised":"$62.5M","founded":"1999","fullurl":"/company_page/biosight","logokey":"$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","urlname":"biosight","employees":"1-10","description":"Therapeutics for Oncology and Hematological Disorders","fundingstage":"Acquired","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":62500000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwL200okKDA","name":"Biond Biologics","hidden":false,"raised":"$37M","founded":"2016","fullurl":"/company_page/biond-biologics","logokey":"$8mrlUXSkMOmWT2wB3hmoAmRSFHenePpQ0CxSv2FCSxM77RvztYvmry","urlname":"biond-biologics","employees":"11-50","description":"Immunotherapies for Cancer and Auto-immune Diseases","fundingstage":"C","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":37000000,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8mrlUXSkMOmWT2wB3hmoAmRSFHenePpQ0CxSv2FCSxM77RvztYvmry","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6_pM4KDA","name":"Gamida Cell","hidden":false,"raised":"$416.22M","founded":"1998","fullurl":"/company_page/gamida-cell","logokey":"$en3ldNUjXmtElFUCM80xLU2SF4I5kExCmXv9w2VUIpPvvDQw7kOyCk","urlname":"gamida-cell","employees":"51-200","description":"Cellular and Immune Therapies","fundingstage":"Acquired","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":413023389,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$en3ldNUjXmtElFUCM80xLU2SF4I5kExCmXv9w2VUIpPvvDQw7kOyCk","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ7f8PILDA","name":"MediWound","hidden":false,"raised":"$198.72M","founded":"2000","fullurl":"/company_page/mediwound","logokey":"$BSARaBKwhcgHTXFwjg9fqJIp6IWqwd7qEH9hp56ls6Nj3FflTtZjRa","urlname":"mediwound","employees":"51-200","description":"Enzymatic Therapeutics for Non-Surgical Tissue Repair","fundingstage":"Public","businessmodel":"B2B2C","minimalprofile":null,"eventvisibility":"Public","publicly_raised":198720000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BSARaBKwhcgHTXFwjg9fqJIp6IWqwd7qEH9hp56ls6Nj3FflTtZjRa","style":"","hiddenCompanyTooltip":""},{"id":"QuKoplMq8CxcsjOFZCawpgtR1oS9VVDBXCeTms0duCYYWNCMI7U5Cd","name":"MemoryPlus","hidden":false,"raised":"undisclosed","founded":"2019","fullurl":"/company_page/memoryplus","logokey":"$hVUM1di6Uar7aYsJ9nRLmIQkuJymBAM8LTRcgOq3eRWz1knvaaM2Yg.png","urlname":"memoryplus","employees":"1-10","description":"Cognition Restoring Treatment for Alzheimer’s Disease","fundingstage":"Pre-Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hVUM1di6Uar7aYsJ9nRLmIQkuJymBAM8LTRcgOq3eRWz1knvaaM2Yg.png","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPmVlcUKDA","name":"Nectin Therapeutics","hidden":false,"raised":"$36M","founded":"2017","fullurl":"/company_page/nectin-therapeutics","logokey":"$qORXS8Vu1j2wfNA0DNbcalolIMwmIFNm8GSboiCTN6S5MF5pnyzjZA.jpeg","urlname":"nectin-therapeutics","employees":"11-50","description":"Next-generation Immunotherapy Agents","fundingstage":"A","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":36000000,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$qORXS8Vu1j2wfNA0DNbcalolIMwmIFNm8GSboiCTN6S5MF5pnyzjZA.jpeg","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkNDc498KDA","name":"Peles Therapeutics","hidden":false,"raised":"undisclosed","founded":"2021","fullurl":"/company_page/peles-therapeutics","logokey":"$nhBGCkUYPSlZqswca5H4dunCFeAngghat16eJRvLeljPTdGbe44bpJ","urlname":"peles-therapeutics","employees":"1-10","description":"Monoclonal Antibody Treatment for Peripheral Artery Disease","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nhBGCkUYPSlZqswca5H4dunCFeAngghat16eJRvLeljPTdGbe44bpJ","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6n6J0IDA","name":"Pharma Two B","hidden":false,"raised":"$46.11M","founded":"2007","fullurl":"/company_page/pharma-two-b","logokey":"$ipUbaIVfODMG1J6vmePtHzbgFSWeU4GNv8Aqnh18YjUA8fWgoqF6kh","urlname":"pharma-two-b","employees":"1-10","description":"Innovative Combinations of Previously Approved Drugs","fundingstage":"C","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":46110000,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ipUbaIVfODMG1J6vmePtHzbgFSWeU4GNv8Aqnh18YjUA8fWgoqF6kh","style":"","hiddenCompanyTooltip":""},{"id":"8VzV5dnlMSswDnHZmbOuzK6cMlAuJor2dnxIvrSnT5y9v0gvJQp9ka","name":"ProPhet","hidden":false,"raised":"$1M","founded":"2024","fullurl":"/company_page/prophet","logokey":"$8ue4OYBKbKPMzVYlnM8vodJ4LFhV99NeAK4Rea0Mgtuo4UvrQx6bWf.jpeg","urlname":"prophet","employees":"1-10","description":"AI-driven Drug Discovery","fundingstage":"Pre-Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8ue4OYBKbKPMzVYlnM8vodJ4LFhV99NeAK4Rea0Mgtuo4UvrQx6bWf.jpeg","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIS73psLDA","name":"SpliSense","hidden":false,"raised":"$41.5M","founded":"2016","fullurl":"/company_page/splisense","logokey":"$JS8BOpidhTStHuEfwGf2V21W0KNz5GXjgiN9ZmN2DYhE9sus6Sw3zY","urlname":"splisense","employees":"11-50","description":"RNA-based Treatment for Genetic Diseases","fundingstage":"B","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":41500000,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$JS8BOpidhTStHuEfwGf2V21W0KNz5GXjgiN9ZmN2DYhE9sus6Sw3zY","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwPqq2pgJDA","name":"TPCera","hidden":false,"raised":"$4.39M","founded":"2016","fullurl":"/company_page/tpcera","logokey":"$2dWQHDgzqRzLYRNvrEIOwbxzAHGz2OkIkBDccnNvEv28SKmCoZwUet","urlname":"tpcera","employees":"1-10","description":"Immunomodulatory Treatment for Autoimmune Diseases","fundingstage":"A","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":3640000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$2dWQHDgzqRzLYRNvrEIOwbxzAHGz2OkIkBDccnNvEv28SKmCoZwUet","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Luasa4JDA","name":"Tamarix Pharma","hidden":false,"raised":"undisclosed","founded":"2020","fullurl":"/company_page/tamarix-pharma","logokey":"$acLcGMJEjWSye8hje4mHQCdC44dB0vs6BZz9BnSI26TdgyLatOJHw4","urlname":"tamarix-pharma","employees":"1-10","description":"Therapies for Apoptosis-driven Diseases","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$acLcGMJEjWSye8hje4mHQCdC44dB0vs6BZz9BnSI26TdgyLatOJHw4","style":"","hiddenCompanyTooltip":""},{"id":"1Sa8PGtegCSYnB7Yf3D1tqKZF5vbXF9DjwsEMkJPN3SRLk0fJHfxRR","name":"TenAces Biosciences","hidden":false,"raised":"undisclosed","founded":"2024","fullurl":"/company_page/tenaces-biosciences","logokey":"$52S5uxhu7v2FKT5Bgrf6cB3rDCGk4zZIdXLCrMarjt9TnxJAoZ7VzC.jpeg","urlname":"tenaces-biosciences","employees":"1-10","description":"Molecular Glue Therapeutics","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$52S5uxhu7v2FKT5Bgrf6cB3rDCGk4zZIdXLCrMarjt9TnxJAoZ7VzC.jpeg","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6q2vAKDA","name":"Vensica Medical","hidden":false,"raised":"$33.2M","founded":"2014","fullurl":"/company_page/vensica-medical","logokey":"$YEeC7RI3uRCmDFrLP71dYNOuL0J0RfMN2OYbUkCzVGRc3RHDZ0x7hp.png","urlname":"vensica-medical","employees":"11-50","description":"Needle-free Drug Delivery System for the Urinary Bladder","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":33200000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YEeC7RI3uRCmDFrLP71dYNOuL0J0RfMN2OYbUkCzVGRc3RHDZ0x7hp.png","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6_0ucLDA","name":"Vidac Pharma","hidden":false,"raised":"$9M","founded":"2012","fullurl":"/company_page/vidac-pharma","logokey":"$wOvE0qdLetkdWPNbns4g3IHKSA5vEvK1zn22wrB05ULZ3ABW3nGedg","urlname":"vidac-pharma","employees":"1-10","description":"Skin Cancer Treatment","fundingstage":"Public","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":9000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wOvE0qdLetkdWPNbns4g3IHKSA5vEvK1zn22wrB05ULZ3ABW3nGedg","style":"","hiddenCompanyTooltip":""}],"investments":[{"date":"Oct 2024","name":"Vensica Medical","amount":11000000,"hidden":false,"islead":1,"country":null,"eventid":"dSvp7iESIoKWwjM0a88hbzOePav0y2tAo45M4HzrdGT8xg9FUh9djt","fullurl":"/company_page/vensica-medical","logokey":"$YEeC7RI3uRCmDFrLP71dYNOuL0J0RfMN2OYbUkCzVGRc3RHDZ0x7hp.png","tagline":"Needle-free Drug Delivery System for the Urinary Bladder","urlname":"/company_page/vensica-medical","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6q2vAKDA","isfollowon":1,"companytype":"Startup","eventamount":"$11M","fundingtype":"Undisclosed Round","investmentid":"a3lHOElsapNfk2EDxDpvMXmM93I5UyPPD3GgcwekaZwsjzuwMVuIgJ","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YEeC7RI3uRCmDFrLP71dYNOuL0J0RfMN2OYbUkCzVGRc3RHDZ0x7hp.png","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jul 2024","name":"ProPhet","amount":1000000,"hidden":false,"islead":0,"country":null,"eventid":"DVy0BWpzkPYQqyWYEdIqHJm3t6DR8bn5dZCj8AdO19NJvVUigLbhLi","fullurl":"/company_page/prophet","logokey":"$8ue4OYBKbKPMzVYlnM8vodJ4LFhV99NeAK4Rea0Mgtuo4UvrQx6bWf.jpeg","tagline":"AI-driven Drug Discovery","urlname":"/company_page/prophet","companyid":"8VzV5dnlMSswDnHZmbOuzK6cMlAuJor2dnxIvrSnT5y9v0gvJQp9ka","isfollowon":0,"companytype":"Startup","eventamount":"$1M","fundingtype":"Pre-Seed","investmentid":"pKVrjtL3yictYIg103nl6H2OLa5ktEyPMv4VPBmkBOylkuGPtRkoU5","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Private","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8ue4OYBKbKPMzVYlnM8vodJ4LFhV99NeAK4Rea0Mgtuo4UvrQx6bWf.jpeg","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2024","name":"TenAces Biosciences","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"mzzWypGW1EDbuam2rcRRCKNGHEQ4vXZIIMaC295yGUSPinjwOpmX4i","fullurl":"/company_page/tenaces-biosciences","logokey":"$52S5uxhu7v2FKT5Bgrf6cB3rDCGk4zZIdXLCrMarjt9TnxJAoZ7VzC.jpeg","tagline":"Molecular Glue Therapeutics","urlname":"/company_page/tenaces-biosciences","companyid":"1Sa8PGtegCSYnB7Yf3D1tqKZF5vbXF9DjwsEMkJPN3SRLk0fJHfxRR","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"VNN3gG8u2UmuUTu8o1vHWuG03W3sSyp2HaTrBR4Lc6uB0YNt362PHh","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":null,"leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$52S5uxhu7v2FKT5Bgrf6cB3rDCGk4zZIdXLCrMarjt9TnxJAoZ7VzC.jpeg","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Feb 2023","name":"MediWound","amount":8030000,"hidden":false,"islead":0,"country":null,"eventid":"BYTYMT7ZRTVLIYKxP6KUlwftNNu2J7xgjM99p2yFwetbc3HRGjPTIH","fullurl":"/company_page/mediwound","logokey":"$BSARaBKwhcgHTXFwjg9fqJIp6IWqwd7qEH9hp56ls6Nj3FflTtZjRa","tagline":"Enzymatic Therapeutics for Non-Surgical Tissue Repair","urlname":"/company_page/mediwound","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ7f8PILDA","isfollowon":0,"companytype":"Startup","eventamount":"$8.03M","fundingtype":"PIPE","investmentid":"88vfTkQPA4NWxO5iXagu1gP9h2XjTY4PZMI8EJaKeIyqXEdVRbWgiJ","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BSARaBKwhcgHTXFwjg9fqJIp6IWqwd7qEH9hp56ls6Nj3FflTtZjRa","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2023","name":"4C Biomed","amount":null,"hidden":false,"islead":1,"country":null,"eventid":"nFz2ySnwnpL3i5ijrm9gY0zyVZgfW29YgS41jl3NUSdgb1TEiyJxbp","fullurl":"/company_page/4c-biomed","logokey":"$thuLc2yHAfwPbQANfHlfRoN9Kx4b1LugzNBAHsNOIjRDB5ajXfhvFb.png","tagline":"Unlocking the Promise of Immune Checkpoint Inhibitors","urlname":"/company_page/4c-biomed","companyid":"I9HARjQF5otmlJD7xWv0oETmwNgLjC6EzFoHbPp20zuFWqzq01jvW4","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"W5W7olJzrF1v8zQ0kwGf5WJT0DbAT427SOcxdAJnriuwZXim1Qubhj","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":null,"leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$thuLc2yHAfwPbQANfHlfRoN9Kx4b1LugzNBAHsNOIjRDB5ajXfhvFb.png","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2022","name":"Nectin Therapeutics","amount":13600000,"hidden":false,"islead":1,"country":null,"eventid":"iuSPMzwBqx7mida61XBDfTYvN40tNFgwtZ9QgRJALeQW294KF9xMSl","fullurl":"/company_page/nectin-therapeutics","logokey":"$qORXS8Vu1j2wfNA0DNbcalolIMwmIFNm8GSboiCTN6S5MF5pnyzjZA.jpeg","tagline":"Next-generation Immunotherapy Agents","urlname":"/company_page/nectin-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPmVlcUKDA","isfollowon":0,"companytype":"Startup","eventamount":"$13.6M","fundingtype":"A Round","investmentid":"g3wq4Ebhf2qd94iKFOse18M6EaW15zNczrla51eCl8vfa6ssURisxQ","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$qORXS8Vu1j2wfNA0DNbcalolIMwmIFNm8GSboiCTN6S5MF5pnyzjZA.jpeg","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2021","name":"AnserBio","amount":750000,"hidden":false,"islead":1,"country":null,"eventid":"CrsmSdJreSk4P0YFn4AbJdRY5xbOVpccl4nXB3VC79spjX27ajdjWR","fullurl":"/company_page/anserbio","logokey":"$T7m2DQr0aDA5tKAOJPDzuBcKKEbBWqXBoFlUtqrEbrfmer65oVGi08","tagline":"Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. - ","urlname":"/company_page/anserbio","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Lq8iIMKDA","isfollowon":1,"companytype":"Startup","eventamount":"$750K","fundingtype":"SAFE","investmentid":"Jq41oSgI2FB5GfJ6E3OlSU0z9gcgJK3v1Nc2nXQh2cQNjuIlgkDn8R","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T7m2DQr0aDA5tKAOJPDzuBcKKEbBWqXBoFlUtqrEbrfmer65oVGi08","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Nov 2021","name":"Vensica Medical","amount":16000000,"hidden":false,"islead":1,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDIqvWWCgw","fullurl":"/company_page/vensica-medical","logokey":"$YEeC7RI3uRCmDFrLP71dYNOuL0J0RfMN2OYbUkCzVGRc3RHDZ0x7hp.png","tagline":"Needle-free Drug Delivery System for the Urinary Bladder","urlname":"/company_page/vensica-medical","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6q2vAKDA","isfollowon":0,"companytype":"Startup","eventamount":"$16M","fundingtype":"Undisclosed Round","investmentid":"498e6c20-dd14-4585-9fd0-9fd874db2b5c","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YEeC7RI3uRCmDFrLP71dYNOuL0J0RfMN2OYbUkCzVGRc3RHDZ0x7hp.png","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jul 2021","name":"Peles Therapeutics","amount":null,"hidden":false,"islead":1,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDg5u2wCAw","fullurl":"/company_page/peles-therapeutics","logokey":"$nhBGCkUYPSlZqswca5H4dunCFeAngghat16eJRvLeljPTdGbe44bpJ","tagline":"Monoclonal Antibody Treatment for Peripheral Artery Disease","urlname":"/company_page/peles-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkNDc498KDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"a9c76289-9e96-44e7-8a08-e30a330c9626","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nhBGCkUYPSlZqswca5H4dunCFeAngghat16eJRvLeljPTdGbe44bpJ","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Mar 2021","name":"SpliSense","amount":28500000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODX8oueCww","fullurl":"/company_page/splisense","logokey":"$JS8BOpidhTStHuEfwGf2V21W0KNz5GXjgiN9ZmN2DYhE9sus6Sw3zY","tagline":"RNA-based Treatment for Genetic Diseases","urlname":"/company_page/splisense","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIS73psLDA","isfollowon":1,"companytype":"Startup","eventamount":"$28.5M","fundingtype":"B Round","investmentid":"bf47da0a-f70b-4a42-aed3-f5cea345f8f6","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$JS8BOpidhTStHuEfwGf2V21W0KNz5GXjgiN9ZmN2DYhE9sus6Sw3zY","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2021","name":"MemoryPlus","amount":null,"hidden":false,"islead":1,"country":null,"eventid":"vcKkwDgHj3yk81lO84kzZjDmf1KMD5O6A1ThR8AFUMIPEjqxyseRJk","fullurl":"/company_page/memoryplus","logokey":"$hVUM1di6Uar7aYsJ9nRLmIQkuJymBAM8LTRcgOq3eRWz1knvaaM2Yg.png","tagline":"Cognition Restoring Treatment for Alzheimer’s Disease","urlname":"/company_page/memoryplus","companyid":"QuKoplMq8CxcsjOFZCawpgtR1oS9VVDBXCeTms0duCYYWNCMI7U5Cd","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Pre-Seed","investmentid":"7OvKSSQ6FnGKxWwh0NzHpsNhtayWNOMkutaPN8BjBFYN25CGwml6Gr","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":null,"leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hVUM1di6Uar7aYsJ9nRLmIQkuJymBAM8LTRcgOq3eRWz1knvaaM2Yg.png","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2021","name":"Tamarix Pharma","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODbjr2CCQw","fullurl":"/company_page/tamarix-pharma","logokey":"$acLcGMJEjWSye8hje4mHQCdC44dB0vs6BZz9BnSI26TdgyLatOJHw4","tagline":"Therapies for Apoptosis-driven Diseases","urlname":"/company_page/tamarix-pharma","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Luasa4JDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Seed","investmentid":"BrI9kP7CFpGlQJqjNKLl6iuZJBhb607KDJbEiESXY8XusmyCaMPNlP","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$acLcGMJEjWSye8hje4mHQCdC44dB0vs6BZz9BnSI26TdgyLatOJHw4","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2021","name":"AnserBio","amount":250000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCT_LXUCAw","fullurl":"/company_page/anserbio","logokey":"$T7m2DQr0aDA5tKAOJPDzuBcKKEbBWqXBoFlUtqrEbrfmer65oVGi08","tagline":"Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. - ","urlname":"/company_page/anserbio","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Lq8iIMKDA","isfollowon":0,"companytype":"Startup","eventamount":"$250K","fundingtype":"SAFE","investmentid":"M28sEdUYzmfIKe2JURhDQhw0t7RyQDHarsVZRpvTxUFLlmKZeaIEiR","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T7m2DQr0aDA5tKAOJPDzuBcKKEbBWqXBoFlUtqrEbrfmer65oVGi08","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2020","name":"BioSight","amount":27000000,"hidden":false,"islead":1,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODW4J-WCgw","fullurl":"/company_page/biosight","logokey":"$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","tagline":"Therapeutics for Oncology and Hematological Disorders","urlname":"/company_page/biosight","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6Y9LoLDA","isfollowon":1,"companytype":"Startup","eventamount":"$27M","fundingtype":"C Round","investmentid":"cef6cc66-b196-4dcb-a94c-cba4961062fe","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Mar 2020","name":"BioSight","amount":19000000,"hidden":false,"islead":1,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD94NOfCAw","fullurl":"/company_page/biosight","logokey":"$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","tagline":"Therapeutics for Oncology and Hematological Disorders","urlname":"/company_page/biosight","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6Y9LoLDA","isfollowon":0,"companytype":"Startup","eventamount":"$19M","fundingtype":"C Round","investmentid":"0f6b1305-2486-447c-ad73-a774f64d5743","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Feb 2020","name":"SpliSense","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCm2u2LCQw","fullurl":"/company_page/splisense","logokey":"$JS8BOpidhTStHuEfwGf2V21W0KNz5GXjgiN9ZmN2DYhE9sus6Sw3zY","tagline":"RNA-based Treatment for Genetic Diseases","urlname":"/company_page/splisense","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIS73psLDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Seed","investmentid":"l6o0TV3Pw00qOcU5jHZkOfFyFu0eWtaxZj3QV07Tv4Ga9bxEyV5C59","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$JS8BOpidhTStHuEfwGf2V21W0KNz5GXjgiN9ZmN2DYhE9sus6Sw3zY","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"May 2019","name":"Ayala Pharmaceuticals","amount":30000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCUz_rHCgw","fullurl":"/company_page/ayala-pharmaceuticals","logokey":"$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","tagline":"Targeted Therapies for People with Rare Cancers","urlname":"/company_page/ayala-pharmaceuticals","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNrZnJ8LDA","isfollowon":1,"companytype":"Startup","eventamount":"$30M","fundingtype":"B Round","investmentid":"dUsWP6URdX2YrYjF6g7QeUVXUChvPeKGZ1RTmEpAXHbEMK3MrQskw3","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2019","name":"Biond Biologics","amount":17000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEtfrMCAw","fullurl":"/company_page/biond-biologics","logokey":"$8mrlUXSkMOmWT2wB3hmoAmRSFHenePpQ0CxSv2FCSxM77RvztYvmry","tagline":"Immunotherapies for Cancer and Auto-immune Diseases","urlname":"/company_page/biond-biologics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwL200okKDA","isfollowon":0,"companytype":"Startup","eventamount":"$17M","fundingtype":"B Round","investmentid":"74b2611a-061f-4997-8af6-16c391b53b41","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":null,"leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8mrlUXSkMOmWT2wB3hmoAmRSFHenePpQ0CxSv2FCSxM77RvztYvmry","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jul 2018","name":"TPCera","amount":3000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEzfyxCAw","fullurl":"/company_page/tpcera","logokey":"$2dWQHDgzqRzLYRNvrEIOwbxzAHGz2OkIkBDccnNvEv28SKmCoZwUet","tagline":"Immunomodulatory Treatment for Autoimmune Diseases","urlname":"/company_page/tpcera","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwPqq2pgJDA","isfollowon":0,"companytype":"Startup","eventamount":"$3M","fundingtype":"A Round","investmentid":"70d73ecb-a38a-4a4f-ae6e-ac86f27883ca","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$2dWQHDgzqRzLYRNvrEIOwbxzAHGz2OkIkBDccnNvEv28SKmCoZwUet","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Apr 2018","name":"Ayala Pharmaceuticals","amount":17000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEyJneCgw","fullurl":"/company_page/ayala-pharmaceuticals","logokey":"$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","tagline":"Targeted Therapies for People with Rare Cancers","urlname":"/company_page/ayala-pharmaceuticals","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNrZnJ8LDA","isfollowon":0,"companytype":"Startup","eventamount":"$17M","fundingtype":"A Round","investmentid":"6310963a-d410-45be-b207-bb84910edce7","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2017","name":"Ayala Pharmaceuticals","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk8IGSCgw","fullurl":"/company_page/ayala-pharmaceuticals","logokey":"$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","tagline":"Targeted Therapies for People with Rare Cancers","urlname":"/company_page/ayala-pharmaceuticals","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNrZnJ8LDA","isfollowon":1,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Seed","investmentid":"23ae32b2-a008-429e-88f4-a0eb175bb30c","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jun 2017","name":"Gamida Cell","amount":40000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk8afuCgw","fullurl":"/company_page/gamida-cell","logokey":"$en3ldNUjXmtElFUCM80xLU2SF4I5kExCmXv9w2VUIpPvvDQw7kOyCk","tagline":"Cellular and Immune Therapies","urlname":"/company_page/gamida-cell","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6_pM4KDA","isfollowon":0,"companytype":"Startup","eventamount":"$40M","fundingtype":"F Round","investmentid":"136ec99e-325b-421b-b135-66cc659dd295","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$en3ldNUjXmtElFUCM80xLU2SF4I5kExCmXv9w2VUIpPvvDQw7kOyCk","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Feb 2017","name":"Pharma Two B","amount":30000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEtoXdCQw","fullurl":"/company_page/pharma-two-b","logokey":"$ipUbaIVfODMG1J6vmePtHzbgFSWeU4GNv8Aqnh18YjUA8fWgoqF6kh","tagline":"Innovative Combinations of Previously Approved Drugs","urlname":"/company_page/pharma-two-b","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6n6J0IDA","isfollowon":0,"companytype":"Startup","eventamount":"$30M","fundingtype":"C Round","investmentid":"6bf1b795-732b-4a69-85bf-28a7e77b4daa","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":null,"leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ipUbaIVfODMG1J6vmePtHzbgFSWeU4GNv8Aqnh18YjUA8fWgoqF6kh","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jun 2016","name":"Vidac Pharma","amount":9000000,"hidden":false,"islead":null,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC4juakCAw","fullurl":"/company_page/vidac-pharma","logokey":"$wOvE0qdLetkdWPNbns4g3IHKSA5vEvK1zn22wrB05ULZ3ABW3nGedg","tagline":"Skin Cancer Treatment","urlname":"/company_page/vidac-pharma","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6_0ucLDA","isfollowon":null,"companytype":"Startup","eventamount":"$9M","fundingtype":"A Round","investmentid":"8f58a69a-a03b-43bb-8b90-49226ca9c23d","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wOvE0qdLetkdWPNbns4g3IHKSA5vEvK1zn22wrB05ULZ3ABW3nGedg","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""}],"team":[{"name":"Yuval Cabilly","email":"yuval@ibf.fund","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPKZ8NIJDA","bounced":false,"claimed":0,"founder":1,"urlname":"yuval-cabilly","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDA8o_kqwgM","position":"Co-founder & Managing Partner","last_name":"Cabilly","claimtoken":"mHwhcFq0YeZQOnqEVDdo2h5qsi794bvo6xhfe9ZqmQakAl9QeoRRSb","first_name":"Yuval","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yuval-cabilly-4a105b50/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-08-03 13:00:40.000000","initials":"YC","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ido Zairi","email":"ido@ibf.fund","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPKPuZYLDA","bounced":false,"claimed":0,"founder":1,"urlname":"ido-zairi","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDA8qa28AkM","position":"Co-founder & Managing Partner","last_name":"Zairi","claimtoken":"Bwv0800e0LxLAD4j1SoYNmk9sz6xSWhsyEYUa6Qu6pJR1SBofHJfhj","first_name":"Ido","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ido-zairi-b980884/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-08-03 13:00:59.000000","initials":"IZ","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"David Sidransky","email":"david@ibf.fund","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPK_iZQIDA","bounced":false,"claimed":0,"founder":1,"urlname":"david-sidransky","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDAirK8ogoM","position":"Co-founder & Managing Partner","last_name":"Sidransky","claimtoken":"z5gPVeYqAC6kBXx9FDL7YEPLaBTm7e1xg9jGd26qs5HikDyTn8Uu16","first_name":"David","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/david-sidransky-0095253/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-08-03 13:01:12.000000","initials":"DS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Elaine Adler","email":"elaine@ibf.fund","phone":"","gender":"Female","userid":"rgsadIESYxhsHXV0hffmhEOsCLCVeothHQh8eT0L2sppUvQgs8cXp9","bounced":false,"claimed":null,"founder":0,"urlname":"elaine-adler","visible":1,"memberid":"tZLLKSCurlcMg8nUoRl8pDeLJtEbTLXlIVdERbh8434MoGkegrFlAn","position":"Senior Analyst","last_name":"Adler","claimtoken":"7eYeFYxRZtjfFhA6B364mXTgBel1ZTqiqW9t8QlLeRVnw2OQKxNK00","first_name":"Elaine","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/elaine-adler/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-08-03 13:04:57.000000","initials":"EA","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":" Sarit  Steinberg","email":"sarit@ibf.fund","phone":"0544655238","gender":"Female","userid":"j60NzGoriARXYCJnFeZYhehU89ZW7wSlvEr77xfRSdW5hMf3cP7CX2","bounced":false,"claimed":1,"founder":0,"urlname":"sarit-steinberg-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgparingkM","position":"Partner","last_name":"Steinberg","claimtoken":"AyTJ1lYlVbpzjOZJNJYKG6YTzdV0uZlWaS3G14HjfaEa0StcHPyILF","first_name":" Sarit ","picturekey":null,"claimeddate":"2022-11-29","linkedinurl":"https://www.linkedin.com/in/sarit-steinberg-9b26a934/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-11-28 19:09:13.000000","initials":" S","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"tags":["life-sciences","biopharmaceutical","biotechnology","pharmaceuticals","drug-discovery"],"targetmarkets":[],"phone":"+972722514175","address":{"israeli":[{"id":"c18795f0-b48a-447c-ba8f-420cb9a0a3a2","city":"Rehovot","type":null,"address":"Prof. Hillel ve-Khanan Oppenheimer St 4, Rehovot, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[]},"headquarter_address":"","news":[{"id":"1e342d96-693d-48fa-b2bb-0998fdb8ac09","date":"May 25, 2022","link":"https://www.globes.co.il/news/article.aspx?did=1001413071","source":"www.globes.co.il","visible":1,"analysis":{"tags":"partnership","company":"לונזה","layoffs":"","summary":"Pharmaceutical company, לונזה, has entered into a unique partnership with Israeli venture capital fund, Israel Biotech Fund (IBF). Under the agreement, לונזה will provide development and manufacturing services for companies in IBFs portfolio, while IBF will help לונזה penetrate the Israeli market. The partnership is expected to accelerate drug development in Israel and reduce risk for לונזה. The companies believe that the collaboration will benefit both parties and lead to innovative business models. Additionally, דן טלמן will join IBF as a partner, bringing his expertise in product development and fundraising.","partners":"Israel Biotech Fund (IBF)","customers":"","investors":"","confidence":8,"key_topics":["partnership","pharmaceuticals","investment","Israeli market","drug development"],"date_of_event":"","valuation_amount":"","impact_on_company":"growth-positive","investment_amount":"","structured_issues":["Partners"],"acquisition_amount":"","structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"rTvUzcJkn4NU43wCLaMkcgccxkibDDBoBycYkaA4IxujVLNLwKDnKU","news_summary":"חברת תרופות בינלאומית תשתף פעולה עם קרן הון סיכון ישראלית","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"0135ff28-3506-45d3-bfed-aa5f32b76793","date":"Apr 5, 2021","link":"https://en.globes.co.il/en/article-israel-biotech-fund-closes-112m-second-fund-1001366337","source":"en.globes.co.il","visible":1,"analysis":{"tags":"investment, partnership, acquisition","company":"Israel Biotech Fund (IBF)","layoffs":null,"summary":"Israel Biotech Fund (IBF) has closed its $112 million second fund, which is larger than its first fund. The main investors in the second fund include Harel Insurance Investments and Financial Services Ltd., Bristol Myers Squibb (BMS), and CBG Capital. IBF focuses on investments in drug development and medical diagnostics companies. Some of IBFs portfolio companies have achieved major milestones, such as Biond Biologics selling the rights to its lead product for treating cancer to Sanofi for a first payment of $125 million. IBF has also partnered with Clal Biotechnology Industries Ltd. to set up a special purpose acquisition company (SPAC) to merge with an Israeli life sciences company. IBF has won the Israel Innovation Authority tender to set up an AI pharma laboratory with partners Pfizer, Astrazeneca, Merck, Teva, and Amazon.","partners":"Clal Biotechnology Industries Ltd.","customers":null,"investors":"Harel Insurance Investments and Financial Services Ltd., Bristol Myers Squibb (BMS), CBG Capital","confidence":9,"key_topics":["IBF second fund","Investors","Portfolio companies","Partnerships","AI pharma laboratory"],"date_of_event":"April 5, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$112 million","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"wO71ZlqaOnEtfE62ktxEkxJyaQq9DBWfEazxnyTmojlp1CDy7sTLdO","news_summary":"Israel Biotech Fund closes $112m second fund","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"421dcdd4-ac35-40c0-9381-533d7d0b3f69","date":"Jul 16, 2019","link":"https://en.globes.co.il/en/article-1st-closure-to-ibf-2nd-fund-1001293653","source":"en.globes.co.il","visible":1,"analysis":{"tags":"investment","company":"Israel Biotech Fund (IBF)","layoffs":null,"summary":"Israel Biotech Fund (IBF) has announced the first closure for its second fund, with the volume and extent undisclosed. IBF was founded in 2015 and has a team of over 25 venture advisors. The portfolio companies of IBFs first fund include Ayala Pharmaceuticals, Pharm Two B, and Biond Biologics. The appointment of venture advisors as directors and advisors for the funds portfolio companies is expected to bring significant changes. The global pharma and biotech industry has been undergoing major changes, resulting in an increase in the number of new drugs approved by the FDA. Israels biotech industry is also showing impressive progress. Prominent investors in IBFs fund include Consensus Business Group (CBG).","partners":null,"customers":null,"investors":["Consensus Business Group (CBG)"],"confidence":9,"key_topics":["Israel Biotech Fund","second fund","closure","investment","portfolio companies"],"date_of_event":"July 16, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YUh21usJ3YvcYDgQFor42MKUMjqURkYf6s80g1L2mufj6SVc2SqhBB","news_summary":"Israel Biotech Fund reports first closure of 2nd fund","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"706f2ad0-3857-42f6-bfb1-d65a80700373","date":"May 10, 2019","link":"https://invivo.pharmaintelligence.informa.com/IV124265/Israel-Looks-To-Nurture-New-Leaders-For-Burgeoning-Biotech-Sector","source":"invivo.pharmaintelligence.informa.com","visible":1,"analysis":{"tags":["biotech","investment","clinical development","Israel"],"company":"OrbiMed","layoffs":35,"summary":"The article discusses the growth and development of Israels biotech sector, with a focus on the role of OrbiMed as an investor. OrbiMed has helped invigorate the sector and bridge the gap between preclinical and clinical development. The article highlights OrbiMeds investment in 89bio, a biotech company focused on developing a drug for nonalcoholic steatohepatitis (NASH). It also mentions Compugen, another Israeli company that has transitioned to clinical trials and formed partnerships with major pharmaceutical companies. The Israel Biotech Fund is also mentioned as a contributor to the growth of the Israeli biotech industry. Overall, the article emphasizes the positive growth and potential of Israels biotech sector.","partners":["Teva","Bristol-Myers Squibb","AstraZeneca"],"customers":null,"investors":["OrbiMed","Longitude Capital","RA Capital Management","Pontifax","Bristol-Myers Squibb","AstraZeneca"],"confidence":8,"key_topics":["Israels biotech sector","OrbiMeds investment in 89bio","Compugens clinical trials and partnerships","Israel Biotech Funds efforts","Israeli biotech industry growth"],"date_of_event":"May 14-16","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$60m","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"txtxOBIRbmLE95qC1sbKNTTgvXL9sVrjVV4DGSI8ipCEaDBz0cQtWU","news_summary":"Israel Looks To Nurture New Leaders For Burgeoning Biotech Sector","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ebbc3200-6231-4083-8dfc-40fb6e207739","date":"Jun 29, 2016","link":"http://www.globes.co.il/en/article-israel-biotech-fund-raises-100m-1001136253","source":"www.globes.co.il","visible":1,"analysis":{"tags":"investment","company":"Israel Biotech Fund","layoffs":null,"summary":"Israel Biotech Fund has selected cancer drug developer Vidac for its first investment. The $100 million fund, managed by Prof. David Sidransky, Ido Zairi, and Dr. Yuval Cabilly, is backed by investors including Biogen, Medison, and an anonymous pharmaceutical company. The fund aims to invest in 8-10 companies and provide consultation to others in the Israeli biotech industry. The founders of the fund have been helping Israeli biotech startups for years and want to establish at least one major Israeli international biotech company. The focus is on supporting companies to reach later stages of clinical trials and obtain suitable budgets.","partners":null,"customers":null,"investors":["Biogen","Medison","anonymous pharmaceutical company"],"confidence":9,"key_topics":["Israel Biotech Fund","Vidac","investment","Israeli biotech industry","cancer drug developer"],"date_of_event":"June 29, 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$100 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"QxapHsAKy9uImk2T5FEYqmy8vxr6mdb5r3FDOwI3eNHD9n0mbDZYMt","news_summary":"Israel Biotech Fund begins investing $100m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":5,"mediagallery":[],"biverification":"Jenny Sotnik-Talisman","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2020-04-01T00:00:00.000Z","crunchbaseid":"israel-biotech-fund","lastupdator":"Ortal Wein","lastupdator_email":"ortalw@sncentral.org","creator":"Ben Yaron","creator_email":"benyaron@gmail.com","createdate":"2016-08-16T00:00:00.000Z","recentupdates":[{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:31.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:30:09.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:07.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:00:40.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2025-03-20 07:18:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:23:23.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:47:30.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:02:25.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:47:12.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:32:02.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:07.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:18.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:44:35.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2025-03-20 07:18:44.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2025-03-20 07:18:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:55.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:23:23.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:04:45.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:47:48.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:10:15.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:29:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:01:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:29:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:01:50.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:07.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:01:12.000000","last_name":"Wein","first_name":"Ortal"},{"email":"yayhosh@gmail.com","source":"Manual","datetime":"2022-11-28 19:09:13.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:01:56.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:23:23.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:43:55.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:01:56.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:23:23.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:55.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2025-03-20 07:18:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:30:38.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 12:59:29.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2025-03-20 07:18:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"yayhosh@gmail.com","source":"Manual","datetime":"2022-11-28 19:09:13.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:47:12.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:33:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:40:59.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:23:23.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:44:18.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:26:10.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:23:23.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:00:59.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2025-03-20 07:18:44.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:04:57.000000","last_name":"Wein","first_name":"Ortal"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-09-23 11:28:26.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-11-01 13:06:41.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2022-05-27 12:20:54.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:30:30.000000","last_name":"Maman","first_name":"Yotam"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2018-08-14 13:15:11.000000","last_name":"McCandless","first_name":"Katie"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2018-08-14 13:15:11.000000","last_name":"McCandless","first_name":"Katie"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:25:48.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:26:26.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:27:53.000000","last_name":"Maman","first_name":"Yotam"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2018-09-01 10:55:02.000000","last_name":"McCandless","first_name":"Katie"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:27:05.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:29:36.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:29:36.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:25:36.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:25:21.000000","last_name":"Maman","first_name":"Yotam"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2017-12-19 11:55:11.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:25:50.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:25:50.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-11-12 14:26:45.000000","last_name":"Maman","first_name":"Yotam"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:37.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:46:39.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:52:15.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:47:23.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:38.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:38.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:41:54.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:39.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:40.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:38.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:40.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:40.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:40.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:40.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:40.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:40.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:40.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:40.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:40.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:40.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:40:39.000000","last_name":"Yaron","first_name":"Ben"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-08-17 14:19:17.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-08-17 14:26:47.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-08-17 14:26:34.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:43:25.000000","last_name":"Yaron","first_name":"Ben"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-08-17 14:26:33.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-08-17 14:26:35.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-08-17 14:26:35.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:41:51.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:42:56.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:46:39.000000","last_name":"Yaron","first_name":"Ben"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-08-17 14:19:21.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-08-17 14:26:34.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2016-08-16 11:52:18.000000","last_name":"Yaron","first_name":"Ben"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2017-02-28 06:32:42.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2017-02-28 06:33:18.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2017-05-24 10:16:27.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2017-05-24 10:20:15.000000","last_name":"Yaron","first_name":"Ben"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-04-06 05:57:42.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-09-04 10:00:02.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-09-04 10:00:02.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-07-16 11:07:29.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-09-04 09:55:25.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-09-04 09:59:42.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-09-04 09:59:42.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-03-07 16:45:55.000000","last_name":"Maman","first_name":"Yotam"},{"email":"vered.waxman@sncentral.org","source":"Manual","datetime":"2020-10-03 19:15:54.000000","last_name":"Waxman","first_name":"Vered"},{"email":"vered.waxman@sncentral.org","source":"Manual","datetime":"2020-10-03 18:57:33.000000","last_name":"Waxman","first_name":"Vered"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-16 10:09:23.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-16 10:09:23.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-16 10:08:51.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-16 10:08:51.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-03-07 16:46:12.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-09-04 10:06:04.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-09-04 09:59:53.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-09-04 09:59:53.000000","last_name":"Maman","first_name":"Yotam"},{"email":"vered.waxman@sncentral.org","source":"Manual","datetime":"2020-10-03 19:19:38.000000","last_name":"Waxman","first_name":"Vered"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-02-06 12:56:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2019-03-31 17:44:16.000000","last_name":"Nielsen","first_name":"L."},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2019-03-31 17:44:16.000000","last_name":"Nielsen","first_name":"L."},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-07-16 11:06:49.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-04-06 05:56:47.000000","last_name":"Maman","first_name":"Yotam"},{"email":"vered.waxman@sncentral.org","source":"Manual","datetime":"2020-10-03 19:19:11.000000","last_name":"Waxman","first_name":"Vered"},{"email":"vered.waxman@sncentral.org","source":"Manual","datetime":"2020-10-03 18:57:34.000000","last_name":"Waxman","first_name":"Vered"},{"email":"vered.waxman@sncentral.org","source":"Manual","datetime":"2020-10-03 19:01:01.000000","last_name":"Waxman","first_name":"Vered"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-16 10:09:07.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-16 10:09:07.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-04-01 06:35:47.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-04-06 07:23:05.000000","last_name":"Maman","first_name":"Yotam"},{"email":"vered.waxman@sncentral.org","source":"Manual","datetime":"2020-10-03 18:56:58.000000","last_name":"Waxman","first_name":"Vered"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-10-07 05:59:27.000000","last_name":"Maman","first_name":"Yotam"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:02:14.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:26:10.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:55.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:30:09.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:02:14.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2025-03-20 07:18:44.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:46:43.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"matane@sncentral.org","source":"Automatic","datetime":"2025-01-27 05:39:21.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:18.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:26:10.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:01:50.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:29:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:04:45.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:36:49.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:02:25.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Automatic","datetime":"2025-03-20 07:18:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2025-03-20 07:18:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:23:23.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:31.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:55.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 12:59:29.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:29:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:18.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:23:23.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:10:15.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:47:30.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"matane@sncentral.org","source":"Automatic","datetime":"2025-01-27 05:39:21.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 12:59:29.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2025-03-20 07:18:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:00:59.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Automatic","datetime":"2025-03-20 07:18:45.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:04:57.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:45:31.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-08-03 13:00:40.000000","last_name":"Wein","first_name":"Ortal"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:47:48.000000","last_name":"Steinberg","first_name":"Sarit"},{"email":"sarit@ibf.fund","source":"Manual","datetime":"2022-11-29 04:46:43.000000","last_name":"Steinberg","first_name":"Sarit"}],"rounds_per_sector":[{"count":24,"sector":"Health Tech & Life Sciences"}],"rounds_per_stage":[{"count":2,"isfollowon":0,"fundingStage":"Pre-Seed"},{"count":1,"isfollowon":1,"fundingStage":"Seed"},{"count":2,"isfollowon":0,"fundingStage":"Seed"},{"count":4,"isfollowon":0,"fundingStage":"A Round"},{"count":1,"isfollowon":0,"fundingStage":"B Round"},{"count":2,"isfollowon":1,"fundingStage":"B Round"},{"count":2,"isfollowon":0,"fundingStage":"C Round"},{"count":1,"isfollowon":1,"fundingStage":"C Round"},{"count":1,"isfollowon":0,"fundingStage":"F Round"},{"count":1,"isfollowon":1,"fundingStage":"SAFE"},{"count":1,"isfollowon":0,"fundingStage":"SAFE"},{"count":1,"isfollowon":0,"fundingStage":"PIPE"},{"count":4,"isfollowon":0,"fundingStage":"Undisclosed"},{"count":1,"isfollowon":1,"fundingStage":"Undisclosed"}],"investment_rounds_over_time":[{"year":2016,"month":6,"record_count":1},{"year":2017,"month":2,"record_count":1},{"year":2017,"month":6,"record_count":1},{"year":2017,"month":12,"record_count":1},{"year":2018,"month":4,"record_count":1},{"year":2018,"month":7,"record_count":1},{"year":2019,"month":1,"record_count":1},{"year":2019,"month":5,"record_count":1},{"year":2020,"month":2,"record_count":1},{"year":2020,"month":3,"record_count":1},{"year":2020,"month":12,"record_count":1},{"year":2021,"month":1,"record_count":3},{"year":2021,"month":3,"record_count":1},{"year":2021,"month":7,"record_count":1},{"year":2021,"month":11,"record_count":1},{"year":2021,"month":12,"record_count":1},{"year":2022,"month":12,"record_count":1},{"year":2023,"month":1,"record_count":1},{"year":2023,"month":2,"record_count":1},{"year":2024,"month":1,"record_count":1},{"year":2024,"month":7,"record_count":1},{"year":2024,"month":10,"record_count":1}],"portfolio_companies_per_sector":[{"count":18,"sector":"Health Tech & Life Sciences"}],"new_portfolio_companies_over_time":[{"year":2016,"month":6,"record_count":1},{"year":2017,"month":2,"record_count":1},{"year":2017,"month":6,"record_count":1},{"year":2018,"month":4,"record_count":1},{"year":2018,"month":7,"record_count":1},{"year":2019,"month":1,"record_count":1},{"year":2020,"month":2,"record_count":1},{"year":2020,"month":3,"record_count":1},{"year":2021,"month":1,"record_count":3},{"year":2021,"month":7,"record_count":1},{"year":2021,"month":11,"record_count":1},{"year":2022,"month":12,"record_count":1},{"year":2023,"month":1,"record_count":1},{"year":2023,"month":2,"record_count":1},{"year":2024,"month":1,"record_count":1},{"year":2024,"month":7,"record_count":1}],"exits_over_time":[{"year":2023,"count":2,"eventType":"MNAEvent"},{"year":2018,"count":1,"eventType":"POEvent"},{"year":2020,"count":3,"eventType":"POEvent"},{"year":2023,"count":1,"eventType":"POEvent"}],"exits_by_sector":[{"count":4,"sector":"Health Tech & Life Sciences"}],"affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODHtOriCAw","date":"2021-04-01","name":"2","title":"Fund 2","amount":100000000,"source":"https://en.globes.co.il/en/article-israel-biotech-fund-closes-112m-second-fund-1001366337","eventtype":"InvestmentFirmFundingEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCnmpP3CQw","date":"2016-10-01","name":"1","title":"Fund 1","amount":66000000,"source":"From Sarit Steinberg","eventtype":"InvestmentFirmFundingEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"style":"","hiddenCompanyTooltip":""}],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"VC and Private Equity","parsedName":"Israel Biotech Fund","logourl":"https://storage.googleapis.com/clean-finder-353810/$YILqEmtVuPhOAI5dVRC7PIVBwe49xO4KSX6J9OAMZzEcIhU9plZyEZ","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$YILqEmtVuPhOAI5dVRC7PIVBwe49xO4KSX6J9OAMZzEcIhU9plZyEZ","teamMembersNumber":5,"section":null,"sectionParams":"","queryParams":"","seoabout":"Israel Biotech Fund (IBF) invests exclusively in Israeli and Israeli related biotech companies at all development stages. Having started its activity in la...","seoTitle":"Israeli VC and Private Equity","serializedCharts":"{\"investmentsRoundsByRoundType\":[{\"fundingStage\":\"Pre-Seed\",\"newInvestments\":2,\"followOnInvestments\":0},{\"fundingStage\":\"Seed\",\"newInvestments\":2,\"followOnInvestments\":1},{\"fundingStage\":\"A Round\",\"newInvestments\":4,\"followOnInvestments\":0},{\"fundingStage\":\"B Round\",\"newInvestments\":1,\"followOnInvestments\":2},{\"fundingStage\":\"C Round\",\"newInvestments\":2,\"followOnInvestments\":1},{\"fundingStage\":\"F Round\",\"newInvestments\":1,\"followOnInvestments\":0},{\"fundingStage\":\"SAFE\",\"newInvestments\":1,\"followOnInvestments\":1},{\"fundingStage\":\"PIPE\",\"newInvestments\":1,\"followOnInvestments\":0},{\"fundingStage\":\"Undisclosed\",\"newInvestments\":4,\"followOnInvestments\":1}],\"investmentRoundsBySector\":[{\"count\":24,\"sector\":\"Health Tech & Life Sciences\"}],\"investmentRoundsOverTime\":[{\"label\":\"2016\",\"count\":1},{\"label\":\"2017\",\"count\":3},{\"label\":\"2018\",\"count\":2},{\"label\":\"2019\",\"count\":2},{\"label\":\"2020\",\"count\":3},{\"label\":\"2021\",\"count\":7},{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":2},{\"label\":\"2024\",\"count\":3},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"portfolioCompaniesBySector\":[{\"count\":18,\"sector\":\"Health Tech & Life Sciences\"}],\"portfolioCompaniesOverTime\":[{\"label\":\"2016\",\"count\":1},{\"label\":\"2017\",\"count\":2},{\"label\":\"2018\",\"count\":2},{\"label\":\"2019\",\"count\":1},{\"label\":\"2020\",\"count\":2},{\"label\":\"2021\",\"count\":5},{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":2},{\"label\":\"2024\",\"count\":2},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"exitsOverTime\":[{\"year\":2023,\"count\":2,\"eventType\":\"MNAEvent\"},{\"year\":2018,\"count\":1,\"eventType\":\"POEvent\"},{\"year\":2020,\"count\":3,\"eventType\":\"POEvent\"},{\"year\":2023,\"count\":1,\"eventType\":\"POEvent\"},{\"year\":2016,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2016,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2017,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2017,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2019,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2019,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2021,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2021,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2022,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2022,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2024,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2024,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2025,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2025,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2026,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2026,\"count\":0,\"eventType\":\"publicExits\"}],\"exitsBySector\":[{\"count\":4,\"sector\":\"Health Tech & Life Sciences\"}]}","statusinfo":"","iiasupport":"","managedAssetsNumber":166000000,"investmentrange":"$250K - $40M","communityinvolvement":[],"foreignInvestments":"","nationality":"Israeli","investorStatistics":{"exitRatio":{"amount":"0"},"investmentFollowOnRatio":{"amount":""},"leadInvestorShare":{"amount":"0"},"soloInvestmentRoundRatio":{"amount":"0"},"firstInvestorRatio":{"amount":"0"}},"popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none"},"mainContact":{}}